Litigation victory for Novo Nordisk on insulin pricing
After six years of litigation, the plaintiffs voluntarily dismissed their case with no recovery of any kind
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Novo Nordisk class certification victory
The district court denied plaintiffs’ motion for class certification in its entirety
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Precigen sale of Trans Ova Genetics to URUS
We are advising Precigen on the transaction
Acutus Medical sale of its left-heart access portfolio products
We are advising Acutus Medical on the transaction
Ingenovis Health acquisition of VISTA Staffing Solutions
We are advising Ingenovis Health, Cornell Capital and Trilantic on the transaction
Novo Nordisk insulin pricing litigation victory
We prevailed in having the complaint dismissed with prejudice
Signify Health defeats bid for preliminary injunction in trade-secret dispute
We secured a favorable resolution of all claims on behalf of Signify
Olympus $500 million senior notes offering
The debut offering consisted of 2.143% senior notes due 2026
Securities litigation victory for Synergy Pharmaceuticals officers and directors
We secured a total victory for the clients, with all claims against them dismissed